CBCT-based online adaptive radiotherapy for head and neck cancer - dosimetric evaluation of first clinical experience
Acta Oncol. 2023 Sep 15:1-6. doi: 10.1080/0284186X.2023.2256966. Online ahead of print.NO ABSTRACTPMID:37713327 | DOI:10.1080/0284186X.2023.2256966 (Source: Acta Oncologica)
Source: Acta Oncologica - September 15, 2023 Category: Cancer & Oncology Authors: K H åkansson E Giannoulis A Lindegaard J Friborg I Vogelius Source Type: research
Treatment of inoperable large cell neuroendocrine lung cancer with single agent temozolomide
Acta Oncol. 2023 Sep 15:1-4. doi: 10.1080/0284186X.2023.2258444. Online ahead of print.NO ABSTRACTPMID:37713358 | DOI:10.1080/0284186X.2023.2258444 (Source: Acta Oncologica)
Source: Acta Oncologica - September 15, 2023 Category: Cancer & Oncology Authors: Annika Marie Ørting Malene Martini Clausen Patrick Soldath Rene H Petersen Ulrich Knigge Mikkel Andreassen Andreas Kj ær Seppo W Langer Source Type: research
Development of a national deep learning-based auto-segmentation model for the heart on clinical delineations from the DBCG RT nation cohort
CONCLUSIONS: This study demonstrated a deep learning-based auto-segmentation model trained on curated clinical delineations which performs on par with a model trained on dedicated delineations, making it easier to develop multi-institutional auto-segmentation models.PMID:37712509 | DOI:10.1080/0284186X.2023.2252582 (Source: Acta Oncologica)
Source: Acta Oncologica - September 15, 2023 Category: Cancer & Oncology Authors: Emma Riis Skars ø Lasse Refsgaard Abhilasha Saini Ditte Sloth M øller Ebbe Laugaard Lorenzen Else Maae Karen Andersen Maja Vestm ø Maraldo Marie Louise Milo Tine Bisballe Nyeng Birgitte Vrou Offersen Stine Sofia Korreman Source Type: research
A systematic planning method to spare the rectal wall in radiotherapy of prostate cancer
Acta Oncol. 2023 Sep 15:1-4. doi: 10.1080/0284186X.2023.2252587. Online ahead of print.NO ABSTRACTPMID:37712583 | DOI:10.1080/0284186X.2023.2252587 (Source: Acta Oncologica)
Source: Acta Oncologica - September 15, 2023 Category: Cancer & Oncology Authors: Kirsten Jakobsen Laura Patricia Kaplan Romain Marsguerra Marko Bebek Kenneth Francis Hoffland Eva Samsoee Hinsby Source Type: research
Current treatment landscape of HR+/HER2- advanced breast cancer in the Nordics: a modified Delphi study
DISCUSSION: ET in combination with a CDK4/6 inhibitor is the preferred frontline treatment for HR+/HER2- aBC in the Nordics. The observed discrepancy between current guidelines and clinical practice could be due to differences in the reimbursement of novel treatments in the Nordics. Collaborative research efforts are warranted for topics that lack consensus.PMID:37713138 | DOI:10.1080/0284186X.2023.2254475 (Source: Acta Oncologica)
Source: Acta Oncologica - September 15, 2023 Category: Cancer & Oncology Authors: J ürgen Geisler Peeter Karihtala Malgorzata Tuxen Antonis Valachis Delphi Panellist Group Barbro Holm Source Type: research
